Carotenoid-inulin fermentation, IBS/overweight microbiota
407 samples from an ex vivo fermentation study (Ghent, Belgium) using fecal microbiota from IBS and overweight adult donors, testing carotenoids combined with the prebiotic inulin; intervention design. machine-written summary
407 samples · 407 runs · BE · Adult · 2026 · 0.55 Gbp / sample
Checked this project's papers and archive records yourself? Mark it human-verified.
what each source gave
| ✓ Sequence archive | 2,442 sample values (collection date, country, latitude, location locality, location region, longitude) |
| ✓ Abstract / description | 407 sample values (health condition detail) |
| ✓ Full text | 814 sample values (antibiotic exposure, smoking status) · PMC13479947 |
| ○ Supplementary tables | files read; no table could be matched to the samples |
| – External resources | not covered by the external resources we ingest |
| – User contribution | nothing uploaded yet · share metadata |
| – Human verified | not yet checked by a person · I checked this project — verify it |
intervention — arms not resolved
Non-microbial dietary supplement (vitamins Prebiotic / dietary fibre supplement design single_arm_before_after · population ibs · Carotenoids (beta-carotene, lutein, lycopene, zeaxanthin) +/- inulin, ex vivo fermentation
“carotenoids tested alone or together with the prebiotic inulin” — bioproject.description (study level; per-sample arms are in the intervention column below)
Genera, mean relative abundance over 405 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).
| field | samples | coverage | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|
| age_category | 407 | 100% | ||||
| country | 407 | 100% | 407 | |||
| health_condition | 0 | 0% | ||||
| subject_id | 0 | 0% | ||||
| antibiotic_exposure | 407 | 100% | 407 | |||
| collection_date | 407 | 100% | 407 | |||
| detailed_location | 407 | 100% | ||||
| health_condition_detail | 407 | 100% | 407 | |||
| latitude | 407 | 100% | 407 | |||
| location_locality | 407 | 100% | 407 | |||
| location_region | 407 | 100% | 407 | |||
| longitude | 407 | 100% | 407 | |||
| smoking_status | 407 | 100% | 407 |
- Carotenoids modulate fermentation of inulin ex vivo in IBS and overweight adult gut microbiota. 2026 PMID 42271199 PMC13479947 own_data
Archive description
Carotenoids have direct antioxidant and anti-inflammatory benefits. Because of their low bioavailability, a portion of carotenoids also reaches the colon, but their interactions with the gut microbiome remain poorly understood.</p><p>Methods: We investigated how beta-carotene (BC), lutein (LU), lycopene (LY), and zeaxanthin (ZE), at biologically relevant doses (1 to 60 mg per day), affect the composition and metabolite production of adult gut microbiota from individuals with irritable bowel syndrome (IBS) and overweight (OW). Experiments were performed using the ex vivo SIFR fermentation system (Systemic Intestinal Fermentation Research). Fresh fecal samples were collected from 12 donors (n = 6 per cohort) and incubated under anaerobic conditions for 24 hours, with carotenoids tested alone or together with the prebiotic inulin (IN, at 2.5 g per day).</p><p>Results: Each cohort showed distinct microbiota profiles at baseline. Carotenoids alone caused only minor changes, but when combined with inulin they significantly altered microbial community composition (Bray-Curtis dissimilarity, P < 0.05) and increased short-chain fatty acid (SCFA) production. Most carotenoids increased butyrate levels compared with inulin alone. ZE at 2 mg per day in IBS (+7.6 percent) and LU at 60 mg per day in OW (+8.0 percent) produced the strongest butyrate increases (P adjusted < 0.10). In contrast, LY at 45 mg per day increased acetate (+3.5 percent) and propionate (+8.0 percent) while reducing butyrate (-7.5 percent, P adjusted < 0.10). SCFA changes were linked to carotenoid- and cohort-specific shifts in the abundance of Bifidobacterium, Alistipes, Akkermansia, Faecalibacterium, and Coprococcus. ZE enhanced the inulin-induced increase of the health-related metabolites 3-phenyllactic acid (PLA) and 2-hydroxyisocaproic acid (HICA), especially in IBS subjects (P adjusted < 0.20).</p><p>Conclusions: Antioxidant carotenoids may support anaerobic gut microbes, including key butyrate producers, and may help counteract phenotype-specific dysbiosis in IBS and overweight individuals. As these benefits occurred when carotenoids were combined with inulin, carotenoids may have stronger effects when consumed with fiber-rich diets, reflecting their natural presence in plant-based foods.
How this project entered the registry
Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.
- host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
- body site study.title · “AND OVERWEIGHT ADULT GUT MICROBIOTA”
- body site study.description · “also reaches the colon , but their”
- life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
- life stage study.title · “IBS AND OVERWEIGHT ADULT GUT MICROBIOTA”
Evidence examples (one per field × route)
| sample | field | value | route | conf. | source | quote |
|---|---|---|---|---|---|---|
| SAMN55871243 | antibiotic_exposure | no | R3 | 0.70 | paper.fulltext.methods_results | no antibiotic/probiotic intake in 3 months prior to study |
| SAMN55871243 | collection_date | 2022 | R1 | 0.90 | biosample.attribute:collection_date | 2022 |
| SAMN55871243 | country | BE | R1 | 0.90 | sample.attr.geo_loc_name | Belgium: Ghent |
| SAMN55871243 | health_condition_detail | mixed_case_control: Two disease groups sampled: IBS (n=6) and overweight (n=6); no healthy controls mentioned | R4 | 0.50 | study.title | IBS AND OVERWEIGHT ADULT GUT MICROBIOTA |
| SAMN55871243 | latitude | 51.0543 | R1 | 0.90 | biosample.attribute:lat_lon | 51.0543 N 3.7174 E |
| SAMN55871243 | location_locality | Ghent | R1 | 0.85 | biosample.attribute:geo_loc_name | Belgium: Ghent |
| SAMN55871243 | location_region | Flanders | R1 | 0.60 | biosample.attribute:lat_lon | 51.0543 N 3.7174 E |
| SAMN55871243 | longitude | 3.7174 | R1 | 0.90 | biosample.attribute:lat_lon | 51.0543 N 3.7174 E |
| SAMN55871243 | smoking_status | never | R3 | 0.70 | paper.fulltext.methods_results | non-smoking |
Sequencing
407 runs over 407 samples · mean 0.74 Gbp per run (median 0.55 Gbp, total 302.58 Gbp; 407 runs with a base count) · layout PAIRED 406, SINGLE 1 · platform ILLUMINA 407 · models Illumina NovaSeq 6000 (407) · 100% of runs with a Sandpiper profile · first public 2026-03-04
Authors (0)
No author record.
Help complete this project
2 of the 4 core fields are below 50% coverage: health_condition, subject_id. Share metadata
Downloads
PRJNA1425773.csv.gz (10.0 KB) · parquet (84.9 KB) — all 407 samples, every field with route and confidence · PRJNA1425773_determinations.csv.gz (20.5 KB) — 3,663 evidence rows